- Home
- ORIC vs SES Comparison
ORIC vs SES Comparison
Compare ORIC & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- SES
- Stock Information
- Founded
- ORIC 2014
- SES 2012
- Country
- ORIC United States
- SES United States
- Employees
- ORIC N/A
- SES N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- SES Auto Parts:O.E.M.
- Sector
- ORIC Health Care
- SES Consumer Discretionary
- Exchange
- ORIC Nasdaq
- SES Nasdaq
- Market Cap
- ORIC 362.9M
- SES 325.9M
- IPO Year
- ORIC 2020
- SES N/A
- Fundamental
- Price
- ORIC $11.10
- SES $0.94
- Analyst Decision
- ORIC Strong Buy
- SES Hold
- Analyst Count
- ORIC 9
- SES 3
- Target Price
- ORIC $18.29
- SES $1.50
- AVG Volume (30 Days)
- ORIC 964.9K
- SES 8.1M
- Earning Date
- ORIC 08-11-2025
- SES 07-28-2025
- Dividend Yield
- ORIC N/A
- SES N/A
- EPS Growth
- ORIC N/A
- SES N/A
- EPS
- ORIC N/A
- SES N/A
- Revenue
- ORIC N/A
- SES $7,833,000.00
- Revenue This Year
- ORIC N/A
- SES $916.42
- Revenue Next Year
- ORIC N/A
- SES $151.67
- P/E Ratio
- ORIC N/A
- SES N/A
- Revenue Growth
- ORIC N/A
- SES N/A
- 52 Week Low
- ORIC $3.90
- SES $0.20
- 52 Week High
- ORIC $14.67
- SES $2.53
- Technical
- Relative Strength Index (RSI)
- ORIC 66.82
- SES 53.33
- Support Level
- ORIC $10.42
- SES $0.85
- Resistance Level
- ORIC $11.50
- SES $0.95
- Average True Range (ATR)
- ORIC 0.62
- SES 0.06
- MACD
- ORIC -0.03
- SES 0.00
- Stochastic Oscillator
- ORIC 83.30
- SES 84.75
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.